Staying One Step Ahead of Osteoporosis ( New studies show key ste...)

Staying One Step Ahead of Osteoporosis

Date:2/26/2009

New studies show key steps to preventing bone loss focus on early screening and treatment

LAS VEGAS, Feb. 26 /PRNewswire-USNewswire/ -- Facts about osteoporosis are staggering. 75 million baby boomers are approaching the age where the disease is tightening its grip on their bones. Osteoporosis (http://orthoinfo.aaos.org/topic.cfm?topic=A00232) also contributes to an estimated 1.5 million bone fractures in the United States annually. According to new information presented today at the 2009 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) (http://www.aaos.org/), new steps to manage bone health and increase communication, will significantly help reduce the rate of fractures and increase the quality of life for the aging population.

"Decreasing the rate of hip fractures saves lives, prevents loss of function, and decreases costs," said Tad Funahashi, MD, regional chief of orthopedic surgery and assistant area medical director for Kaiser Permanente Southern California, and clinical professor of orthopaedic surgery at the University of California Irvine's College of Medicine. "If we screen for osteoporosis at the earliest onset of the disease," said Dr. Funahashi, "we can implement treatment and help to decrease the rate of hip fractures by 45 percent." Hip Fractures and Osteoporosis Study 474 (http://www3.aaos.org/education/anmeet/anmt2009/podium/podium.cfm?Pevent=474)

Osteoporosis is also a huge pr
'/>"/>

1

GOOD

Page: 1 2 3 4
Related medicine technology :

1. Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
2. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
6. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
7. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
8. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
9. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
10. Radius Completes Enrollment of Phase II Clinical Trial of BA058 for Osteoporosis
11. Phase III Data Published for Once Monthly Dose of Risedronate to Treat Postmenopausal Osteoporosis

Post Your Comments:

Staying One Step Ahead of Osteoporosis( New studies show key ste...),Health